This brand name is authorized in Austria, Brazil, Cyprus, Ecuador, Estonia, Spain, France, Hong Kong, Croatia, Ireland, Italy, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, South Africa
The drug ROTARIX contains one active pharmaceutical ingredient (API):
|
1
Human rotavirus live attenuated
UNII KZ3L01D2PC - HUMAN ROTAVIRUS A TYPE G1P(8) STRAIN RIX4414 LIVE ANTIGEN
|
|
Rotavirus vaccine is indicated for the active immunisation of infants aged 6 to 24 weeks for prevention of gastroenteritis due to rotavirus infection. In clinical trials, efficacy was demonstrated against gastro-enteritis due to rotavirus of the most common genotypes G1P [8], G2P [4], G3P [8], G4P [8] and G9P [8]. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| ROTARIX Powder and solvent for oral suspension | European Medicines Agency (EU) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| J07BH01 | Rota virus, live attenuated | J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BH Rota virus diarrhea vaccines |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 510618020059307 |
| Country: EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | Identifier(s): 29094-11-09 |
| Country: EE | Ravimiamet | Identifier(s): 1250727, 1250738, 1250749, 1250750, 1477537, 1477548, 1477559, 1477560, 1477571, 1477582, 1477593, 1791301 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 05330005IP, 05330005IP1, 05330005IP2, 05330009, 05330009IP |
| Country: FR | Base de données publique des médicaments | Identifier(s): 60886387 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 346100 |
| Country: HK | Department of Health Drug Office | Identifier(s): 54546 |
| Country: IT | Agenzia del Farmaco | Identifier(s): 037045010, 037045022, 037045034, 037045046, 037045059, 037045061, 037045073, 037045085, 037045097, 037045109, 037045111, 037045123 |
| Country: JP | 医薬品医療機器総合機構 | Identifier(s): 631300AS1020 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1030731, 1030732, 1030733, 1030734, 1056565, 1056566, 1056567, 1056568, 1056569, 1056570, 1056571, 1086095 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 108413, 204048 |
| Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 11925, 13344 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100159915, 100197347 |
| Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W51710001, W51710002, W51710003, W51710004, W53550001, W53550002, W53550003, W53550004, W53550005, W53550006, W53550007 |
| Country: SG | Health Sciences Authority | Identifier(s): 13150P, 13743P, 13813P |
| Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 7063122 |
| Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8699522967582, 8699522967599, 8699522967605, 8699522967612, 8699522967636, 8699522967643, 8699522967650 |
| Country: ZA | Health Products Regulatory Authority | Identifier(s): 43/30.2/0290 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
